These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

129 related articles for article (PubMed ID: 17894532)

  • 1. Comparison of two approaches for treating cascade impaction mass balance measurements.
    Wyka B; Tougas T; Mitchell J; Strickland H; Christopher D; Lyapustina S
    J Aerosol Med; 2007; 20(3):236-56. PubMed ID: 17894532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Product Quality Research Institute evaluation of cascade impactor profiles of pharmaceutical aerosols. Part 3. Final report on a statistical procedure for determining equivalence.
    Christopher D; Adams W; Amann A; Bertha C; Byron PR; Doub W; Dunbar C; Hauck W; Lyapustina S; Mitchell J; Morgan B; Nichols S; Pan Z; Singh GJ; Tougas T; Tsong Y; Wolff R; Wyka B
    AAPS PharmSciTech; 2007 Nov; 8(4):E90. PubMed ID: 18181550
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro and in vivo aspects of cascade impactor tests and inhaler performance: a review.
    Mitchell J; Newman S; Chan HK
    AAPS PharmSciTech; 2007 Dec; 8(4):E110. PubMed ID: 18181531
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Quality assurance test of delivered dose uniformity of multiple-dose inhaler and dry powder inhaler drug products.
    Tsong Y; Dong X; Shen M; Lostritto RT
    J Biopharm Stat; 2015; 25(2):328-38. PubMed ID: 25357132
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effect of inherent variability of inhalation products on impactor mass balance limits.
    Bagger-Jörgensen H; Sandell D; Lundbäck H; Sundahl M
    J Aerosol Med; 2005; 18(4):367-78. PubMed ID: 16379613
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Discriminating Ability of Abbreviated Impactor Measurement Approach (AIM) to Detect Changes in Mass Median Aerodynamic Diameter (MMAD) of an Albuterol/Salbutamol pMDI Aerosol.
    David Christopher J; Patel RB; Mitchell JP; Tougas TP; Goodey AP; Quiroz J; Andersson PU; Lyapustina S
    AAPS PharmSciTech; 2017 Nov; 18(8):3296-3306. PubMed ID: 28589305
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Particle Size Measurements from Orally Inhaled and Nasal Drug Products.
    Mitchell JP
    J Aerosol Med Pulm Drug Deliv; 2021 Dec; 34(6):325-345. PubMed ID: 34860563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Improved quality control metrics for cascade impaction measurements of orally inhaled drug products (OIPs).
    Tougas TP; Christopher D; Mitchell JP; Strickland H; Wyka B; Van Oort M; Lyapustina S
    AAPS PharmSciTech; 2009; 10(4):1276-85. PubMed ID: 19882251
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Determination of Passive Dry Powder Inhaler Aerodynamic Particle Size Distribution by Multi-Stage Cascade Impactor: International Pharmaceutical Aerosol Consortium on Regulation & Science (IPAC-RS) Recommendations to Support Both Product Quality Control and Clinical Programs.
    Mitchell JP; Stein SW; Doub W; Goodey AP; Christopher JD; Patel RB; Tougas TP; Lyapustina S
    AAPS PharmSciTech; 2019 May; 20(5):206. PubMed ID: 31147791
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Application of the modified chi-square ratio statistic in a stepwise procedure for cascade impactor equivalence testing.
    Weber B; Lee SL; Delvadia R; Lionberger R; Li BV; Tsong Y; Hochhaus G
    AAPS J; 2015 Mar; 17(2):370-9. PubMed ID: 25515206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The effect of nonideal cascade impactor stage collection efficiency curves on the interpretation of the size of inhaler-generated aerosols.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2013 Jun; 14(2):497-510. PubMed ID: 23508617
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Non-impactor-based methods for sizing of aerosols emitted from orally inhaled and nasal drug products (OINDPs).
    Mitchell J; Bauer R; Lyapustina S; Tougas T; Glaab V
    AAPS PharmSciTech; 2011 Sep; 12(3):965-88. PubMed ID: 21785912
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of methods to measure aerosols generated by a vibrating mesh nebulizer.
    Waldrep JC; Berlinski A; Dhand R
    J Aerosol Med; 2007; 20(3):310-9. PubMed ID: 17894537
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Measurement of Aerodynamic Particle Size Distribution of Orally Inhaled Products by Cascade Impactor: How to Let the Product Specification Drive the Quality Requirements of the Cascade Impactor.
    Roberts DL; Mitchell JP
    AAPS PharmSciTech; 2019 Jan; 20(2):57. PubMed ID: 30623259
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Minimizing variability of cascade impaction measurements in inhalers and nebulizers.
    Bonam M; Christopher D; Cipolla D; Donovan B; Goodwin D; Holmes S; Lyapustina S; Mitchell J; Nichols S; Pettersson G; Quale C; Rao N; Singh D; Tougas T; Van Oort M; Walther B; Wyka B
    AAPS PharmSciTech; 2008; 9(2):404-13. PubMed ID: 18431675
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Relative precision of inhaler aerodynamic particle size distribution (APSD) metrics by full resolution and abbreviated andersen cascade impactors (ACIs): part 1.
    Mitchell JP; Nagel MW; Doyle CC; Ali RS; Avvakoumova VI; Christopher JD; Quiroz J; Strickland H; Tougas T; Lyapustina S
    AAPS PharmSciTech; 2010 Jun; 11(2):843-51. PubMed ID: 20480271
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro/in vivo comparisons in pulmonary drug delivery.
    Newman SP; Chan HK
    J Aerosol Med Pulm Drug Deliv; 2008 Mar; 21(1):77-84. PubMed ID: 18518834
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Pharmacopeial methodologies for determining aerodynamic mass distributions of ultra-high dose inhaler medicines.
    Wong W; Crapper J; Chan HK; Traini D; Young PM
    J Pharm Biomed Anal; 2010 Mar; 51(4):853-7. PubMed ID: 19932579
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Addressing the Need for Controls on Particle Bounce and Re-entrainment in the Cascade Impactor and for the Mitigation of Electrostatic Charge for Aerodynamic Particle Size Assessment of Orally Inhaled Products: an Assessment by the International Consortium on Regulation and Science (IPAC-RS).
    Doub W; Stein S; Mitchell J; Goodey AP
    AAPS PharmSciTech; 2020 Aug; 21(7):239. PubMed ID: 32827121
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cascade impactors for the size characterization of aerosols from medical inhalers: their uses and limitations.
    Mitchell JP; Nagel MW
    J Aerosol Med; 2003; 16(4):341-77. PubMed ID: 14977427
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.